RCM
MDT icon

Riverhead Capital Management’s Medtronic MDT Stock Holding History

Riverhead Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$2.99M Buy
27,550
+8,453
+44% +$882K 0.11% 236
2019
Q2 		$1.86M Buy
19,097
+6,510
+52% +$594K 0.07% 354
2019
Q1 		$1.15M Buy
12,587
+1,067
+9% +$95.5K 0.05% 441
2018
Q4 		$1.05M Sell
11,520
-2,811
-20% -$263K 0.05% 434
2018
Q3 		$1.41M Sell
14,331
-320
-2% -$29.6K 0.05% 394
2018
Q2 		$1.25M Buy
14,651
+3,494
+31% +$292K 0.05% 407
2018
Q1 		$895K Sell
11,157
-21
-0.2% -$1.73K 0.04% 457
2017
Q4 		$903K Buy
11,178
+2,478
+28% +$198K 0.04% 458
2017
Q3 		$677K Sell
8,700
-750
-8% -$62.3K 0.03% 506
2017
Q2 		$839K Sell
9,450
-126
-1% -$10.6K 0.04% 427
2017
Q1 		$771K Buy
9,576
+2,626
+38% +$205K 0.04% 419
2016
Q4 		$495K Sell
6,950
-1,100
-14% -$86.4K 0.03% 503
2016
Q3 		$696K Sell
8,050
-259,828
-97% -$22.6M 0.04% 384
2016
Q2 		$13.3M Buy
267,878
+176,059
+192% +$14.2M 0.43% 56
2016
Q1 		$6.89M Sell
91,819
-113,106
-55% -$8.52M 0.1% 269
2015
Q4 		$15.8M Sell
204,925
-308,734
-60% -$23.2M 0.23% 111
2015
Q3 		$34.4M Sell
513,659
-264,753
-34% -$19.5M 0.54% 39
2015
Q2 		$57.7M Buy
778,412
+204,647
+36% +$15.6M 0.87% 12
2015
Q1 		$44.7M Buy
573,765
+365,549
+176% +$27.7M 0.67% 26
2014
Q4 		$15M Buy
208,216
+104,245
+100% +$7.24M 0.23% 130
2014
Q3 		$6.44M Buy
103,971
+5,900
+6% +$375K 0.11% 251
2014
Q2 		$6.25M Buy
98,071
+12,483
+15% +$758K 0.12% 252
2014
Q1 		$5.27M Sell
85,588
-539
-0.6% -$31.4K 0.12% 240
2013
Q4 		$4.94M Buy
86,127
+31,627
+58% +$1.79M 0.13% 222
2013
Q3 		$2.9M Sell
54,500
-242,000
-82% -$13M 0.09% 246
2013
Q2 		$15.3M Buy
+296,500
New +$14.7M 0.51% 53

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Riverhead Capital Management's MDT Position: Q3 2019 in Review

Riverhead Capital Management increased its Medtronic (MDT) stake by 44% in Q3 2019, buying an estimated $882K and bringing the position to 27,550 shares worth $2.99M. The position accounts for 0.11% of the portfolio, ranked #236.

Riverhead Capital Management first reported a position in MDT in Q2 2013 and has held it in 26 quarters since. The position peaked at $57.7M in Q2 2015. 1,645 funds tracked by Wall St. Rank hold MDT as of Q3 2019.

  • Riverhead Capital Management held 27,550 shares of Medtronic worth $2.99M as of Q3 2019.
  • Riverhead Capital Management bought 8,453 Medtronic shares in Q3 2019, an estimated $882K.
  • Medtronic made up 0.11% of Riverhead Capital Management's portfolio in Q3 2019, its #236 holding.
  • Riverhead Capital Management first reported a position in Medtronic in Q2 2013 and has held it in 26 quarters since.
  • Riverhead Capital Management's Medtronic position peaked at $57.7M in Q2 2015.
  • 1,645 funds tracked by Wall St. Rank held Medtronic as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.